Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study

(2015) Lucette A Cysique et al.   BMC Neurology

Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments

(2015) K.M. Mothapo et al.   JOURNAL OF NEUROIMMUNOLOGY

The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV

(2014) E. R. Hammond et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

(2014) R. K. Heaton et al.   CLINICAL INFECTIOUS DISEASES

Cortical sources of resting-state EEG rhythms in “experienced” HIV subjects under antiretroviral therapy

(2014) Claudio Babiloni et al.   CLINICAL NEUROPHYSIOLOGY

Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men

(2014) Jeffrey McDonnell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Biomarkers in dementia: clinical utility and new directions

(2014) R M Ahmed et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prevalence and predictors of blood-brain barrier damage in the HAART era

(2014) A. Calcagno et al.   JOURNAL OF NEUROVIROLOGY

The role of tau protein in HIV-associated neurocognitive disorders

(2014) Lecia AM Brown et al.   Molecular Neurodegeneration

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection

(2014) Julia Peterson et al.   PLoS One

Neuroimaging of HIV-associated neurocognitive disorders (HAND)

(2014) Beau M. Ances et al.   Current Opinion in HIV and AIDS

Treatment of HIV in the CNS: Effects of Antiretroviral Therapy and the Promise of Non-Antiretroviral Therapeutics

(2014) Michael J. Peluso et al.   Current HIV/AIDS Reports

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy

(2013) Aylin Yilmaz et al.   Journal of Neuroinflammation

HIV and Neurocognitive Dysfunction

(2013) Serena Spudich   Current HIV/AIDS Reports

The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment

(2012) Benjamin B. Gelman et al.   PLoS One

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

(2011) Ronald J. Ellis et al.   AIDS

Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism

(2011) E. A. Eugenin et al.   JOURNAL OF NEUROSCIENCE

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

(2010) Lars Hagberg et al.   AIDS Research and Therapy

Gene Expression Profiles of HIV-1-Infected Glia and Brain: Toward Better Understanding of the Role of Astrocytes in HIV-1-Associated Neurocognitive Disorders

(2009) Alejandra Borjabad et al.   Journal of Neuroimmune Pharmacology